Erica Mayer, MD
Dana-Farber Cancer Institute
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Erica Mayer, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:31 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06001762 · TRADE: Dose Escalation Tolerability of Abemaciclib in HR+ HER2- Early Stage Breast CancerDana-Farber Cancer Institute · active not recruiting · Breast Cancer, Early-stage Breast Cancer, High Risk Breast Carcinoma · principal investigator
- Ph3NCT02513394 · PALbociclib CoLlaborative Adjuvant StudyAlliance Foundation Trials, LLC. · active not recruiting · Breast Cancer · principal investigator
- Ph2NCT02040857 · Palbociclib in Combination With Adjuvant Endocrine Therapy for Hormone Receptor Positive, HER2 Negative Invasive Breast CancerDana-Farber Cancer Institute · completed · Breast Cancer · principal investigator
- Ph2NCT01982448 · Cisplatin vs Paclitaxel for Triple Negative Breast CancerDana-Farber Cancer Institute · completed · Triple Negative Breast Cancer · principal investigator
- Ph2NCT01827787 · Eribulin in HER2 Negative Metastatic BrCaDana-Farber Cancer Institute · completed · Breast Cancer · principal investigator
- Ph2NCT00925652 · Bevacizumab, Metronomic Chemotherapy (CM), Diet and Exercise After Preoperative Chemotherapy for Breast CancerDana-Farber Cancer Institute · terminated · Breast Cancer · study chair
- N/ANCT00674011 · Hypertension in Breast Cancer Patients Receiving BevacizumabDana-Farber Cancer Institute · terminated · Breast Cancer · principal investigator
- Ph1NCT00496665 · ZD6474 (Zactima) and Metronomic Chemotherapy in Advanced Breast CancerDana-Farber Cancer Institute · completed · Metastatic Breast Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:31 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in breast cancer.